title: Alendronate increases bone mineral density in long-term renal transplant recipients.
authors.affiliation: University School of Medicine, Division of Nephrology, Istanbul, Turkey.
authors.forename: M
authors.initials: M
authors.lastname: Koc
authors.forename: S
authors.initials: S
authors.lastname: Tuglular
authors.forename: H
authors.initials: H
authors.lastname: Arikan
authors.forename: C
authors.initials: C
authors.lastname: Ozener
authors.forename: E
authors.initials: E
authors.lastname: Akoglu
mesh_terms: D015502:Absorptiometry, Photon; D000328:Adult; D019386:Alendronate / Q000627:therapeutic use*; D015519:Bone Density / Q000187:drug effects*; D002117:Calcitriol / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000009:adverse effects / Q000502:physiology*; D008297:Male; D011183:Postoperative Complications / Q000601:surgery; D012086:Reoperation; D013997:Time Factors; D017211:Treatment Failure
chemical_list: D007166:Immunosuppressive Agents; D002117:Calcitriol; D019386:Alendronate